Production & Distribution

Working closely with Glycosyn and Glycosyn’s manufacturing partners, GHI is responsible for optimizing the distribution of Glycosyn’s hMOS and other inventions to those underserved populations that need it the most, at little or no cost to the child, family and community in need. These include infants and children in the developing world, high-risk refugee populations, disaster victims, and populations experiencing epidemics caused by cholera and other pathogens. The product is stable at room temperature, would be taken orally as part of a drink or nutriment, and is intrinsically pleasant-tasting. Moreover, repeated use against pathogens does not result in resistance or diminished protection.

GHI anticipates availability of various quantities of hMOS for distribution, beginning with 2’-fucosyllactose (2’-FL), which will begin appearing in infant formula and other health and wellness products in 2017.

Partner for production:

  • Glycosyn
  • FrieslandCampina

Partner for Distribution:

  • Strong local presence
  • On the ground distribution capacity
  • Non-profit commitment to kids in need